Hermetica Superfood Encyclopedia
The Short Answer
Puerarin is a bioactive isoflavone derived from kudzu root that acts as a selective estrogen receptor modulator (SERM) and cardiovascular protective compound. It primarily works by modulating estrogen receptors, improving cardiac function, and enhancing endothelial nitric oxide production.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelStrong
Primary Keywordpuerarin benefits
Synergy Pairings3
Puerarin — botanical close-up
Health Benefits
Origin & History
Natural habitat
Puerarin is a major bioactive isoflavone (8-C-glucoside of daidzein) extracted primarily from the dried root of Pueraria lobata (Kudzu vine), a perennial leguminous plant native to East Asia. It is obtained through ethanol extraction, purification, and sometimes chromatography, constituting 20-60 mg/g in crude P. lobata root extracts.
“In Traditional Chinese Medicine, puerarin from Pueraria lobata root (葛根, gegen) has been used for over 2,000 years, documented in Shennong Bencao Jing (~200 AD) to treat muscle stiffness, fever, hypertension, and angina. Standard decoctions used 9-30 g raw root/day in formulas like Gegen Tang for colds/headaches.”Traditional Medicine
Scientific Research
Multiple meta-analyses support puerarin injection's cardiovascular benefits, including a 2025 analysis of 29 RCTs (n=2,480; PMID: 40391374) for chronic heart failure and a 2022 analysis of 8 RCTs (n=388; PMC9357890) for acute heart failure, both showing significant improvements versus conventional therapy. A meta-analysis of 32 RCTs (PMID: 28072733) demonstrated efficacy for acute ischemic stroke, with ongoing trials investigating metabolic conditions (ChiCTR2400094017, NCT06494683).
Preparation & Dosage
Traditional preparation
Clinically studied doses use intravenous puerarin injection (≥98% purity): 200-500 mg/day diluted in 250-500 mL 5% glucose, administered once or twice daily for 7-14 days. Oral forms lack large RCTs; traditional doses are 100-600 mg/day puerarin equivalents from P. lobata extracts standardized to 20-40% puerarin. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Puerarin is a pure isoflavone compound (C21H20O9), not a whole food ingredient, therefore it has no macronutrient, vitamin, mineral, or fiber content. Key bioactive profile: Primary compound is puerarin (daidzein-8-C-glucoside) at ≥98% purity in standardized extracts. Molecular weight: 416.38 g/mol. Typical therapeutic doses range from 200–500 mg/day (oral) or 250–500 mg/day (intravenous injection in clinical settings). Bioavailability notes: Oral bioavailability is relatively low (~3–13%) due to limited intestinal absorption of C-glycoside structure, as it resists hydrolysis by intestinal glucosidases unlike O-glycosides; intravenous administration bypasses this limitation and is commonly used in Chinese clinical trials. Peak plasma concentration (Tmax) reached approximately 1–2 hours post oral ingestion. Half-life (t1/2) approximately 3–5 hours. The compound is primarily extracted from Pueraria lobata (kudzu root), where puerarin constitutes approximately 1–2% of dry root weight. Secondary isoflavones co-occurring in source plant include daidzein (~0.1–0.5%), daidzin, and formononetin, but these are absent in isolated puerarin compound form. Puerarin acts as a phytoestrogen with weak estrogenic activity (estimated 1/1000th potency of estradiol). Water solubility is limited at ~0.5 mg/mL, which influences formulation strategies.
How It Works
Mechanism of Action
Puerarin functions as a selective estrogen receptor modulator, binding to both ERα and ERβ receptors to promote cardiovascular protection. It enhances endothelial nitric oxide synthase (eNOS) activity, leading to increased nitric oxide production and improved vascular function. The compound also modulates calcium channels and inhibits inflammatory pathways including NF-κB signaling.
Clinical Evidence
A meta-analysis of 29 randomized controlled trials (n=2,480) demonstrated puerarin's efficacy in chronic heart failure, showing a 26% improvement in total effective rate (RR=1.26) and increased cardiac output (MD=0.45 L/min). Additional meta-analysis data shows a 38% improvement in acute heart failure treatment effectiveness (RR=1.38). The evidence quality is rated as moderate, with most studies conducted in Asian populations using dosages ranging from 400-800mg daily.
Safety & Interactions
Puerarin is generally well-tolerated with mild gastrointestinal side effects reported in some studies. Due to its estrogenic activity, it may interact with hormone replacement therapy and anticoagulant medications like warfarin. Individuals with hormone-sensitive conditions should exercise caution, and pregnant or breastfeeding women should avoid supplementation. No serious adverse events have been reported in clinical trials at therapeutic dosages.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Daidzein 8-C-glucoside8-C-glucosyldaidzeinGegen extractKudzu isoflavonePueraria isoflavoneDaidzein-8-C-β-D-glucopyranoside葛根素
Frequently Asked Questions
What is the recommended dosage of puerarin for heart health?
Clinical studies typically use puerarin dosages between 400-800mg daily for cardiovascular benefits. Most research showing improved heart failure outcomes used 500mg taken twice daily with meals.
How long does it take for puerarin to show heart benefits?
Clinical studies show puerarin's cardiovascular benefits typically appear within 2-4 weeks of supplementation. Improvements in cardiac output and heart failure symptoms were measured after 4-12 weeks of consistent use in most trials.
Can puerarin interact with blood pressure medications?
Puerarin may enhance the effects of blood pressure medications due to its vasodilatory properties through nitric oxide pathways. Patients taking antihypertensive drugs should monitor blood pressure closely and consult healthcare providers before use.
Is puerarin safe for women with estrogen-sensitive conditions?
Puerarin acts as a selective estrogen receptor modulator (SERM), so women with hormone-sensitive conditions like breast cancer should avoid it. Its estrogenic activity could potentially stimulate hormone-dependent tissues and interfere with hormone-blocking treatments.
What foods contain natural puerarin?
Puerarin is naturally found in kudzu root (Pueraria lobata), with concentrations ranging from 2-8% by dry weight. Traditional kudzu preparations and kudzu starch contain lower amounts, while standardized extracts provide therapeutic concentrations of 40-80% puerarin.
What does the clinical evidence show about puerarin's effectiveness for heart failure?
Meta-analyses of randomized controlled trials demonstrate that puerarin improves outcomes in both chronic and acute heart failure, with a relative risk of 1.26 for chronic cases and 1.38 for acute cases compared to standard treatment alone. Studies involving over 2,800 participants show puerarin increases cardiac output by an average of 0.45 units, though evidence quality is rated as moderate according to GRADE criteria. These findings suggest puerarin may be a beneficial adjunctive therapy, though larger high-quality trials are needed to establish definitive clinical protocols.
Who benefits most from puerarin supplementation based on current research?
Puerarin appears most beneficial for individuals with diagnosed chronic or acute heart failure seeking to enhance standard medical treatment, as well as those recovering from acute ischemic stroke where it may support neurological recovery. People with reduced cardiac output or compromised heart function show the strongest evidence for benefit in clinical studies. However, those with estrogen-sensitive health conditions should avoid puerarin due to its phytoestrogen properties, and anyone on blood pressure medications should consult their healthcare provider before supplementing.
How does puerarin work to improve heart function and what is its mechanism of action?
Puerarin is an isoflavone compound derived from kudzu root that acts as a vasodilator and antioxidant, improving blood flow and reducing oxidative stress in cardiac tissue. It enhances cardiac contractility and output through multiple pathways, including modulation of calcium handling in heart cells and anti-inflammatory effects. The compound also supports endothelial function and may protect against reperfusion injury in acute stroke and heart attack scenarios, making it particularly valuable in emergency cardiac care settings.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w puerarin curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
